Marc Van Maanen PhD
About Marc Van Maanen PhD
Marc Van Maanen, PhD, is the Senior Director and Cell Therapy CMC Team Lead at Bristol Myers Squibb, with extensive experience in biopharmaceuticals and a background in molecular virology and biochemistry.
Title
Marc Van Maanen PhD holds the position of Senior Director, Cell Therapy CMC Team Lead at Bristol Myers Squibb in the United States.
Current Role at Bristol Myers Squibb
Marc Van Maanen PhD currently serves as the Senior Director, Cell Therapy CMC Team Lead at Bristol Myers Squibb. His role involves overseeing cell therapy research and development, ensuring compliance with regulatory standards, and leading cross-functional teams. He is based on-site in the United States.
Previous Roles at Thermo Fisher Scientific
From 2016 to 2024, Marc Van Maanen PhD worked at Thermo Fisher Scientific in various capacities. From 2020 to 2024, he was the Director of Biologics Commercial Operations, which he managed remotely from New Jersey. Previously, from 2016 to 2020, he served as the Site Head and Director of Program Management in Princeton, New Jersey, where he led cross-functional teams in biologics development programs.
Experience at Merck
Marc Van Maanen PhD had a substantial tenure at Merck from 2008 to 2016. He initially engaged as a Research Fellow, followed by roles as a Senior Project Scientist, and later as a Principal Scientist and CMC Analytical Program Lead. His work at Merck spanned locations such as West Point, PA; Rahway, NJ; and Kenilworth, NJ, focusing on scientific research and program management in biologics and cell therapies.
Education and Academic Background
Marc Van Maanen PhD has an extensive academic background in biochemistry, molecular biology, and virology. He earned his PhD in Biochemistry and Molecular Biology from The University of Western Australia and completed a Post-doctoral Fellowship in Molecular Virology/Lentiviral Vectors from Baylor College of Medicine. He also holds a Bachelor of Science (B.Sc.) First Class in Virology from The University of Western Australia.